Increased rectal microbial richness is associated with the presence of colorectal adenomas in humansOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study asked whether the adherent gut microbiota differs between people with and without colorectal adenomas, precursors to colorectal cancer. Researchers sampled mucosal biopsies rather than stool. They used 454 titanium pyrosequencing of the V1-V2 region of the 16S ribosomal RNA gene to characterize bacterial communities. The team compared microbial richness and taxon abundance between adenoma cases and controls, and weighed the microbial difference against clinical risk factors.
Who was studied?
The cohort was 71 humans: 33 subjects with colorectal adenomas and 38 without adenomas serving as controls. Both men and women were included, with many participants of middle age. Rectal mucosal biopsy samples were analyzed to capture bacteria adherent to the gut wall. This was a case-control human study, not an animal or in-vitro model. Clinical parameters including obesity, diet, and family history of colorectal cancer were recorded for comparison.
What were the most important findings?
Adenoma cases carried a richer adherent microbiota. Biopsies from people with adenomas had greater abundance of bacteria from 87 taxa than controls, while only 5 taxa were more abundant in control samples. This microbial difference between adenoma patients and controls was more pronounced than any other clinical parameter measured, including obesity, diet, and family history of colorectal cancer. This pointed to increased distal gut microbial richness as a distinguishing feature of adenoma presence.
What are the greatest implications of this study?
The findings suggest that sequence analysis of the mucosal microbiota could help identify people at risk of developing colorectal adenomas. Microbial richness outperformed traditional risk factors in distinguishing cases from controls. Because this is a cross-sectional, case-control design, it cannot establish whether microbial changes cause adenomas or arise alongside them. The sample size was modest. The results support further work on the gut microbiota as a potential biomarker for colorectal neoplasia screening.